<?xml version="1.0" encoding="utf-8"?>
<rss version="2.0" xmlns:media="http://search.yahoo.com/mrss/">
<channel>
                    <title>Clinical pharmacology</title>
            <link>https://medicalxpress.com/medications-news/</link>
            <language>en-us</language> 
            <description>Latest medical news and research in Clinical pharmacology</description>

                            <item>
                    <title>Possible new treatment for Wilson disease seeks to minimize effects on mitochondria using metformin</title>
                    <description>Wilson disease is a rare genetic condition in which the liver loses the ability to effectively remove copper, allowing it to accumulate in the body. This toxic buildup affects the liver, brain, eyes and kidneys and is particularly bad for mitochondria, the cell&#039;s all-important power plants.</description>
                    <link>https://medicalxpress.com/news/2026-11-treatment-wilson-disease-minimize-effects.html</link>
                    <category></category>
                    <pubDate>Thu, 19 Nov 2026 17:20:02 EST</pubDate>
                    <guid isPermaLink="false">news714324541</guid>
                                            <media:thumbnail url="https://scx1.b-cdn.net/csz/news/tmb/2026/possible-new-treatment.jpg" width="90" height="90" />
                                    </item>
                            <item>
                    <title>One Health collaboration leads to potential targets against leishmaniasis, a parasitic disease</title>
                    <description>Leishmania parasites cause leishmaniasis. The disease is spread through the bite of an infected sand fly. While in the bloodstream, parasites invade host cells where they live and multiply.</description>
                    <link>https://medicalxpress.com/news/2026-11-health-collaboration-potential-leishmaniasis-parasitic.html</link>
                    <category></category>
                    <pubDate>Thu, 19 Nov 2026 16:40:01 EST</pubDate>
                    <guid isPermaLink="false">news714323761</guid>
                                            <media:thumbnail url="https://scx1.b-cdn.net/csz/news/tmb/2026/one-health-collaborati.jpg" width="90" height="90" />
                                    </item>
                            <item>
                    <title>Therapeutic antibody protects against all three pathogenic human coronaviruses</title>
                    <description>A therapeutic antibody (bispecific nanobody) developed by researchers at Georgia State University and collaborators neutralized all three highly pathogenic human coronaviruses (SARS-CoV, SARS-CoV-2 and MERS-CoV) and protected animals from viral infections, according to a study published in the journal ACS Nano.</description>
                    <link>https://medicalxpress.com/news/2026-11-therapeutic-antibody-pathogenic-human-coronaviruses.html</link>
                    <category></category>
                    <pubDate>Thu, 19 Nov 2026 09:40:08 EST</pubDate>
                    <guid isPermaLink="false">news714301741</guid>
                                            <media:thumbnail url="https://scx1.b-cdn.net/csz/news/tmb/2026/therapeutic-antibody-p-1.jpg" width="90" height="90" />
                                    </item>
                            <item>
                    <title>Neurosteroid offers clues to brain changes linked to depression</title>
                    <description>UT Southwestern Medical Center researchers and colleagues, including two at UT Dallas, have found evidence that pregnenolone—a naturally occurring steroid hormone the body produces from cholesterol—may alter patterns of communication between key brain regions involved in depression and cognitive control.</description>
                    <link>https://medicalxpress.com/news/2026-11-neurosteroid-clues-brain-linked-depression.html</link>
                    <category></category>
                    <pubDate>Thu, 19 Nov 2026 05:20:09 EST</pubDate>
                    <guid isPermaLink="false">news714286581</guid>
                                            <media:thumbnail url="https://scx1.b-cdn.net/csz/news/tmb/2026/neurosteroid-offers-cl.jpg" width="90" height="90" />
                                    </item>
                            <item>
                    <title>CBD oil offers no behavioral benefit for youths with intellectual disability, new study finds</title>
                    <description>Cannabis contains two key compounds that act on the brain: cannabidiol (CBD) and tetrahydrocannabinol (THC). Although both interact with the body&#039;s endocannabinoid system, the outcomes of consuming them are poles apart. THC is the compound responsible for marijuana&#039;s intoxicating high and can sometimes trigger adverse effects, including psychosis. CBD, on the other hand, is associated with potential anxiety-relieving and anti-inflammatory effects. Despite limited evidence that it works, over the last decade, CBD-rich medical cannabis has gained popularity as a treatment for behavioral problems in children with autism spectrum disorder (ASD).</description>
                    <link>https://medicalxpress.com/news/2026-11-cbd-oil-behavioral-benefit-youths.html</link>
                    <category></category>
                    <pubDate>Wed, 18 Nov 2026 15:40:20 EST</pubDate>
                    <guid isPermaLink="false">news714235473</guid>
                                            <media:thumbnail url="https://scx1.b-cdn.net/csz/news/tmb/2026/cbd-oil-offers-no-beha.jpg" width="90" height="90" />
                                    </item>
                            <item>
                    <title>Novel compound eases paralysis and activates nerve repair pathways in multiple sclerosis mouse model</title>
                    <description>A new derivative of a natural compound reduced symptoms associated with multiple sclerosis and promoted the central nervous system&#039;s regenerative pathways in a mouse model, report researchers at the University of Illinois Urbana-Champaign and collaborators at Keio University and Chiba University in Japan.</description>
                    <link>https://medicalxpress.com/news/2026-11-compound-eases-paralysis-nerve-pathways.html</link>
                    <category></category>
                    <pubDate>Wed, 18 Nov 2026 15:00:04 EST</pubDate>
                    <guid isPermaLink="false">news714235082</guid>
                                            <media:thumbnail url="https://scx1.b-cdn.net/csz/news/tmb/2026/novel-compound-improve.jpg" width="90" height="90" />
                                    </item>
                            <item>
                    <title>Inspired by &#039;Flowers for Algernon,&#039; experimental nose drops improve memory in mice</title>
                    <description>Researchers at the University of Sydney have developed experimental nose drops that enhance learning and memory in aged mice while also preventing memory loss in a mouse model of Alzheimer&#039;s disease. The treatment uses mRNA technology similar to that developed for use in COVID-19 vaccines.</description>
                    <link>https://medicalxpress.com/news/2026-11-algernon-experimental-nose-memory-mice.html</link>
                    <category></category>
                    <pubDate>Wed, 18 Nov 2026 05:00:01 EST</pubDate>
                    <guid isPermaLink="false">news714127081</guid>
                                            <media:thumbnail url="https://scx1.b-cdn.net/csz/news/tmb/2026/experimental-nose-drop.jpg" width="90" height="90" />
                                    </item>
                            <item>
                    <title>GLP-1 weight-loss drugs linked to inadequate intake of key nutrients in some people</title>
                    <description>Drugs taken to suppress appetite, such as Wegovy and Mounjaro, are associated with inadequate intakes of key nutrients and energy in some people, finds a small exploratory study published in the journal BMJ Nutrition Prevention &amp; Health.</description>
                    <link>https://medicalxpress.com/news/2026-11-glp-weight-loss-drugs-linked.html</link>
                    <category></category>
                    <pubDate>Tue, 17 Nov 2026 18:30:06 EST</pubDate>
                    <guid isPermaLink="false">news714054841</guid>
                                            <media:thumbnail url="https://scx1.b-cdn.net/csz/news/tmb/2026/person-taking-suppleme.jpg" width="90" height="90" />
                                    </item>
                            <item>
                    <title>First successful human challenge model for dengue serotype 4 could speed vaccine and drug testing</title>
                    <description>Researchers at the University of Maryland School of Medicine (UMSOM) and the Institute of Human Virology (IHV) have developed the first successful human challenge model for dengue serotype 4, a major advance that could speed the development of new drugs and vaccines against a strain of the dengue virus that remains difficult to study.</description>
                    <link>https://medicalxpress.com/news/2026-11-successful-human-dengue-serotype-vaccine.html</link>
                    <category></category>
                    <pubDate>Tue, 17 Nov 2026 16:20:28 EST</pubDate>
                    <guid isPermaLink="false">news714152402</guid>
                                            <media:thumbnail url="https://scx1.b-cdn.net/csz/news/tmb/2017/dengue.jpg" width="90" height="90" />
                                    </item>
                            <item>
                    <title>Tirzepatide moves more than half of treated teens below obesity threshold, new clinical trial reports</title>
                    <description>Tirzepatide (Zepbound) is a once-weekly injectable medication that hits two targets at once. This dual-action drug mimics the effects of two natural gut hormones in the body—glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1). Working together, these hormones keep blood sugar in check, slow the movement of food through the gut and signal the brain about fullness, which helps manage appetite and food intake.</description>
                    <link>https://medicalxpress.com/news/2026-11-tirzepatide-teens-obesity-threshold-clinical.html</link>
                    <category></category>
                    <pubDate>Tue, 17 Nov 2026 08:30:04 EST</pubDate>
                    <guid isPermaLink="false">news714126561</guid>
                                            <media:thumbnail url="https://scx1.b-cdn.net/csz/news/tmb/2026/tirzepatide-moved-more.jpg" width="90" height="90" />
                                    </item>
                            <item>
                    <title>Researchers find potential way to protect the brain from HIV and opioid damage</title>
                    <description>People living with HIV continue to struggle with memory loss, difficulty concentrating and poor decision-making, even as antiretroviral treatments have dramatically improved life expectancy. For patients who also use opioids—which may be prescribed to manage the chronic pain that can accompany HIV—these cognitive problems can be even worse. Until now, scientists haven&#039;t understood exactly why.</description>
                    <link>https://medicalxpress.com/news/2026-11-potential-brain-hiv-opioid.html</link>
                    <category></category>
                    <pubDate>Mon, 16 Nov 2026 15:40:06 EST</pubDate>
                    <guid isPermaLink="false">news714061502</guid>
                                            <media:thumbnail url="https://scx1.b-cdn.net/csz/news/tmb/2019/8-brain.jpg" width="90" height="90" />
                                    </item>
                            <item>
                    <title>This time, the virus is on the patient&#039;s side. AI helped design it</title>
                    <description>AI can write emails, create seasoning blends or put pets in Renaissance outfits. One adventurous baker used ChatGPT to concoct a cake from sauerkraut and seaweed. Now, there&#039;s an AI-made virus on the scene.</description>
                    <link>https://medicalxpress.com/news/2026-11-virus-patient-side-ai.html</link>
                    <category></category>
                    <pubDate>Mon, 16 Nov 2026 13:40:17 EST</pubDate>
                    <guid isPermaLink="false">news714052201</guid>
                                            <media:thumbnail url="https://scx1.b-cdn.net/csz/news/tmb/2024/virus.jpg" width="90" height="90" />
                                    </item>
                            <item>
                    <title>Ending Medicaid coverage for weight-loss drugs linked to sharp drop in GLP-1 use</title>
                    <description>Medicaid prescriptions for weight loss–approved GLP-1 medications fell sharply after four states ended coverage of the drugs, according to a new study led by researchers at the University of Pittsburgh. The findings, published in JAMA, demonstrate how state coverage decisions can have an immediate and substantial effect on access to these medications.</description>
                    <link>https://medicalxpress.com/news/2026-11-medicaid-coverage-weight-loss-drugs.html</link>
                    <category></category>
                    <pubDate>Mon, 16 Nov 2026 11:00:09 EST</pubDate>
                    <guid isPermaLink="false">news714033754</guid>
                                            <media:thumbnail url="https://scx1.b-cdn.net/csz/news/tmb/2026/glp-1-medications.jpg" width="90" height="90" />
                                    </item>
                            <item>
                    <title>HIV drug lenacapavir found to disrupt virus formation, creating giant noninfectious particles</title>
                    <description>Lenacapavir is a powerful, long-acting drug used to prevent and treat HIV infection. While it is known to block key steps in the virus&#039;s replication after entering a cell, researchers have now uncovered another way the drug works: it disrupts the formation of new virus particles, causing them to become abnormally large and noninfectious.</description>
                    <link>https://medicalxpress.com/news/2026-11-hiv-drug-lenacapavir-disrupt-virus.html</link>
                    <category></category>
                    <pubDate>Mon, 16 Nov 2026 09:20:06 EST</pubDate>
                    <guid isPermaLink="false">news714042925</guid>
                                            <media:thumbnail url="https://scx1.b-cdn.net/csz/news/tmb/2026/hiv-drug-lenacapavir-f-1.jpg" width="90" height="90" />
                                    </item>
                            <item>
                    <title>RNA switch lets drugs control gene therapy protein production</title>
                    <description>Bioengineers at the University of California San Diego have developed a technology that allows drugs to control when cells produce therapeutic proteins, which could potentially make gene therapies safer and more adaptable for treating chronic diseases.</description>
                    <link>https://medicalxpress.com/news/2026-11-rna-drugs-gene-therapy-protein.html</link>
                    <category></category>
                    <pubDate>Fri, 13 Nov 2026 16:20:06 EST</pubDate>
                    <guid isPermaLink="false">news713800922</guid>
                                            <media:thumbnail url="https://scx1.b-cdn.net/csz/news/tmb/2026/new-rna-switch-could-m.jpg" width="90" height="90" />
                                    </item>
                            <item>
                    <title>GLP-1s often contain untested additive combinations, study finds</title>
                    <description>Use of GLP-1 receptor agonist medications (GLP-1s) has skyrocketed in recent years, and many people are using &quot;compounded&quot; GLP-1 products: medicines that include GLP-1s as well as other active substances, some of which are not regulated by the FDA. A new study found that compounded GLP-1s now make up a large majority of weight-loss medicines, commonly containing vitamin B12 analogs that have not been tested for safety in combination with GLP-1s.</description>
                    <link>https://medicalxpress.com/news/2026-11-glp-1s-untested-additive-combinations.html</link>
                    <category></category>
                    <pubDate>Fri, 13 Nov 2026 16:00:01 EST</pubDate>
                    <guid isPermaLink="false">news713800264</guid>
                                            <media:thumbnail url="https://scx1.b-cdn.net/csz/news/tmb/2026/glp-1-medications.jpg" width="90" height="90" />
                                    </item>
                    </channel>
</rss>
